RxDoctor Payments Data

Robert Wilson, MD

Interventional Pain Medicine · Salisbury, NCNPI 1962473496

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,250 of the $37,303 with a category attached, or 70.4%. Boston Scientific accounts for 98.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $22,588 and has fallen 97.1% since, to $650 in 2025. Among interventional pain medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,303in general payments, 2019–2025

Across 444 payments — averaging $84.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$37K
  • SPR Therapeutics, Inc$273
  • Scilex Pharmaceuticals Inc.$121
  • Vertiflex, Inc.$81
  • GRT US Holding, Inc.$58
  • Arbor Pharmaceuticals, Inc.$37
  • plus $194 from 10 others
$57,960in research payments, 2019–2025

Across 14 payments — averaging $4140.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$58K

What the payments were for

  • Consulting fees$4501%
  • Speaking & faculty fees$26,25070%
  • Travel & lodging$2,8458%
  • Food & beverage$7,75821%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,303 in reported general payments places this provider in the 95th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$363,342
Medicare patients
354
Services billed
5,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen381$11,722
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen176$5,854
Oxycodone Hcl188$5,088
Morphine Sulfate ErMorphine Sulfate60$3,832
Gabapentin133$3,690
Fentanyl14$1,657
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine25$1,296
Lidocaine18$1,244
Tramadol Hcl161$1,197
Tizanidine Hcl39$435
Pregabalin25$377
Hydromorphone Hcl18$306
Cephalexin18$255
Alprazolam14$233
Duloxetine Hcl11$232

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →